Basic research studies to understand aneurysm disease

被引:43
作者
Boddy, Amy M. [1 ]
Lenk, Guy M.
Lillvis, John H. [1 ]
Nischan, Jennifer [1 ]
Kyo, Yoshiki [2 ]
Kuivaniemi, Helena [1 ]
机构
[1] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA
[2] Higashihirosima Med Ctr, Dept Cardiovasc Surg, Hiroshima, Japan
关键词
D O I
10.1358/dnp.2008.21.3.1203410
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Abdominal aortic aneurysm (AAA) is a complex multifactorial disease with life-threatening implications. Aneurysms typically have no signs or symptoms, and rupture of AAA has a high mortality rate. Multiple environmental and genetic risk factors are involved in aneurysm formation and progression making it a complicated disease to study. Little is understood about the mechanisms in disease initiation, thus there are currently no therapeutic approaches to prevent AAA, leaving patients with surgery as their only option. Ongoing research into the genetic components of AAA using a candidate gene approach has been overall unsuccessful. A more promising approach to study complex diseases involves genome-wide techniques such as DNA linkage analysis, genetic association studies and microarray expression profiling. Furthermore, studies involving inhibition of AAA progression, rather than formation, have a potentially promising outcome. Targeting biological pathways in AAA pathogenesis may benefit patients by slowing the growth and possibly preventing the rupture of AAA. Critical pathways involved in AAA pathogenesis include immunological processes, such as T-cell and natural killer cell pathways, oxidative stress, depletion of vascular smooth muscle cells through the process of apoptosis and the destruction of the extracellular matrix by matrix metalloproteinases. (C) 2008 Prous Science, S.A.U. or its licensors. All rights reserved.
引用
收藏
页码:142 / 148
页数:7
相关论文
共 67 条
[21]   Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms [J].
Henderson, EL ;
Gang, YJ ;
Sukhova, GK ;
Whittemore, AD ;
Knox, J ;
Libby, P .
CIRCULATION, 1999, 99 (01) :96-104
[22]   Elastin stabilization for treatment of abdominal aortic aneurysms [J].
Isenburg, Jason C. ;
Simionescu, Dan T. ;
Starcher, Barry C. ;
Vyavahare, Narendra R. .
CIRCULATION, 2007, 115 (13) :1729-1737
[23]   Nitric oxide in experimental aneurysm formation: Early events and consequences of nitric oxide inhibition [J].
Johanning, JM ;
Armstrong, PJ ;
Franklin, DP ;
Han, DC ;
Carey, DJ ;
Elmore, JR .
ANNALS OF VASCULAR SURGERY, 2002, 16 (01) :65-72
[24]  
Keeling W Brent, 2005, Vasc Endovascular Surg, V39, P457, DOI 10.1177/153857440503900601
[25]   Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II -induced abdominal aortic aneurysm formation in mice [J].
King, VL ;
Trivedi, DB ;
Gitlin, JM ;
Loftin, CD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) :1137-1143
[26]  
KOCH AE, 1990, AM J PATHOL, V137, P1199
[27]   Aortic aneurysms - An immune disease with a strong genetic component [J].
Kuivaniemi, Helena ;
Platsoucas, Chris D. ;
Tilson, M. David, III .
CIRCULATION, 2008, 117 (02) :242-252
[28]   RACIAL-DIFFERENCES IN THE INCIDENCE OF FEMORAL BYPASS AND ABDOMINAL AORTIC ANEURYSMECTOMY IN MASSACHUSETTS - RELATIONSHIP TO CARDIOVASCULAR RISK-FACTORS [J].
LAMORTE, WW ;
SCOTT, TE ;
MENZOIAN, JO .
JOURNAL OF VASCULAR SURGERY, 1995, 21 (03) :422-431
[29]   Rapamycin suppresses experimental aortic aneurysm growth [J].
Lawrence, DM ;
Singh, RS ;
Franklin, DP ;
Carey, DJ ;
Elmore, JR .
JOURNAL OF VASCULAR SURGERY, 2004, 40 (02) :334-338
[30]   Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms [J].
Lenk, Guy M. ;
Tromp, Gerard ;
Weinsheimer, Shantel ;
Gatalica, Zoran ;
Berguer, Ramon ;
Kuivaniemi, Helena .
BMC GENOMICS, 2007, 8 (1) :237